Company Filing History:
1 out of 4 
1 out of 34 
1 out of 42 
Years Active: 2021
Title: Mi Ha Ju: Innovator in Cancer Treatment
Introduction
Mi Ha Ju is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of specialized ribozymes.
Latest Patents
One of Mi Ha Ju's notable patents is titled "Cancer-specific trans-splicing ribozymes and use thereof." This invention focuses on a cancer-specific trans-splicing ribozyme that selectively targets cancer tissue while sparing normal tissue. This specificity ensures a high level of safety and excellent expression efficiency at the post-transcription level, making it a promising tool for cancer treatment.
Career Highlights
Throughout his career, Mi Ha Ju has worked with various organizations, including Rznomics Inc. and the Dong-a University Research Foundation for Industry-Academy Cooperation. His work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Mi Ha Ju has collaborated with notable colleagues such as Seong-Wook Lee and Chang Ho Lee. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Mi Ha Ju's work in developing cancer-specific trans-splicing ribozymes represents a significant advancement in cancer treatment. His dedication to innovation continues to inspire progress in the medical field.